Reduction of serum cholesterol is cardioprotective even in patients with chronic renal insufficiency and renal failure-main results of the SHARP study

Abstract

Chronic kidney disease, c ardiovascular risk, serum cholesterol, renal failure, main results of the SHARP study, microalbuminuria, angiotensin antagonist, aliskiren, dyslipidemia, endothelin antagonist

Keywords

• Chronic kidney disease
• cardiovascular risk
• serum cholesterol
• renal failurel
• main results of the SHARP study